THBS1 overexpression
|
Ovarian Cancer
|
THBS1 overexpression
|
Ovarian Cancer
|
CaT Sensitive: C3 – Early Trials
|
CaT Sensitive: C3 – Early Trials
|
THBS1 overexpression
|
Breast Cancer
|
THBS1 overexpression
|
Breast Cancer
|
docetaxel + doxorubicin hydrochloride Resistant: C3 – Early Trials
|
docetaxel + doxorubicin hydrochloride Resistant: C3 – Early Trials
|
THBS1 overexpression
|
Breast Cancer
|
THBS1 overexpression
|
Breast Cancer
|
FEC Resistant: C3 – Early Trials
|
FEC Resistant: C3 – Early Trials
|